Welcia Holdings Co., Ltd. (TYO:3141)
3,040.00
+1.00 (0.03%)
Oct 24, 2025, 12:45 PM JST
Welcia Holdings Revenue
Welcia Holdings had revenue of 344.37B JPY in the quarter ending August 31, 2025, with 5.68% growth. This brings the company's revenue in the last twelve months to 1.33T, up 7.79% year-over-year. In the fiscal year ending February 28, 2025, Welcia Holdings had annual revenue of 1.29T with 5.56% growth.
Revenue (ttm)
1.33T
Revenue Growth
+7.79%
P/S Ratio
0.47
Revenue / Employee
80.26M
Employees
16,611
Market Cap
632.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1.29T | 67.67B | 5.56% |
| Feb 29, 2024 | 1.22T | 73.06B | 6.38% |
| Feb 28, 2023 | 1.14T | 118.33B | 11.53% |
| Feb 28, 2022 | 1.03T | 76.30B | 8.03% |
| Feb 28, 2021 | 949.65B | 81.37B | 9.37% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |